Literature DB >> 16283483

MRI detection of early bone metastases in b16 mouse melanoma models.

Karen M Gauvain1, Joel R Garbow, Sheng-Kwei Song, Angela C Hirbe, Katherine Weilbaecher.   

Abstract

Bone metastasis causes significant morbidity in cancer patients, including bone pain, pathologic fractures, nerve compression syndrome, and hypercalcemia. Animal models are utilized to study the pathogenesis of skeletal metastases and to evaluate potential therapeutic agents. Previously published methods for imaging bone metastasis in rodent models have focused on identifying advanced stage metastasis using simple X-rays. Here we report MRI as a method for detecting early bone metastases in mouse models in vivo. B16 mouse melanoma cells were injected into the left cardiac ventricle of C57BL/6 mice and magnetic resonance (MR) images were obtained of the left leg following the development of metastatic disease, when tumor associated bone destruction was histologically present but not visible by X-ray. T1 and T2 relaxation times of bone marrow were measured in healthy control mice and B16 melanoma tumor-bearing mice. Mean T2 values for normal marrow were 28 ms (SD 5) and for diseased bone marrow were 41 ms (SD 3). T2 relaxation time of diseased bone marrow is significantly longer than that of normal bone marrow (P < 0.0001) and can be used as a marker of early bone metastases. These studies demonstrate that MR imaging can detect bone marrow metastases in small animals prior to development of cortical bone loss identified by X-ray.

Entities:  

Mesh:

Year:  2005        PMID: 16283483      PMCID: PMC2726655          DOI: 10.1007/s10585-005-1264-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  42 in total

1.  A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.

Authors:  S Eustace; R Tello; V DeCarvalho; J Carey; J T Wroblicka; E R Melhem; E K Yucel
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

2.  Animal model of human medulloblastoma: clinical, magnetic resonance imaging, and histopathological findings after intra-cisternal injection of MHH-MED-1 cells into nude rats.

Authors:  M Schabet; J Martos; R Buchholz; T Pietsch
Journal:  Med Pediatr Oncol       Date:  1997-08

3.  Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging.

Authors:  H Poptani; A M Puumalainen; O H Gröhn; S Loimas; R Kainulainen; S Ylä-Herttuala; R A Kauppinen
Journal:  Cancer Gene Ther       Date:  1998 Mar-Apr       Impact factor: 5.987

4.  A new xenograft model of primary central nervous system lymphoma.

Authors:  M Saini; M Bellinzona; W Weichhold; M Samii
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

5.  Noninvasive 3D MR microscopy as a tool in pharmacological research: application to a model of rheumatoid arthritis.

Authors:  N Beckmann; K Bruttel; A Mir; M Rudin
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

6.  Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases.

Authors:  F W Flickinger; S M Sanal
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

7.  Interleukin-2/sodium butyrate treatment cures rats bearing liver tumors after acquired 5-fluorouracil resistance.

Authors:  S Cordel; B Dupas; J Y Douillard; K Meflah
Journal:  Int J Cancer       Date:  1998-12-09       Impact factor: 7.396

8.  Disseminated neuroblastoma in the nude rat. A xenograft model of human malignancy.

Authors:  D A Martinez; S Kahwash; M S O'Dorisio; T V Lloyd; R B McGhee; S J Qualman
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

Review 9.  Mechanisms of the development of osteoblastic metastases.

Authors:  D Goltzman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

10.  Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.

Authors:  J R Berenson; A Lichtenstein; L Porter; M A Dimopoulos; R Bordoni; S George; A Lipton; A Keller; O Ballester; M J Kovacs; H A Blacklock; R Bell; J Simeone; D J Reitsma; M Heffernan; J Seaman; R D Knight
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

View more
  12 in total

1.  CT-based handling and analysis of preclinical multimodality imaging data of bone metastases.

Authors:  Thomas J A Snoeks; Martin Baiker; Eric L Kaijzel; Boudewijn P F Lelieveldt; Clemens W G M Löwik
Journal:  Bonekey Rep       Date:  2012-05-09

2.  Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy.

Authors:  Deep K Hathi; John A Engelbach; Jens Hillengass; Deborah Veis; Samuel Achilefu; Joel R Garbow; Monica Shokeen
Journal:  NMR Biomed       Date:  2019-06-17       Impact factor: 4.044

3.  FDG small animal PET permits early detection of malignant cells in a xenograft murine model.

Authors:  Cristina Nanni; Korinne Di Leo; Roberto Tonelli; Cinzia Pettinato; Domenico Rubello; Antonello Spinelli; Silvia Trespidi; Valentina Ambrosini; Paolo Castellucci; Mohsen Farsad; Roberto Franchi; Andrea Pession; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-08       Impact factor: 9.236

4.  Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model.

Authors:  Jeannine Missbach-Guentner; Christian Dullin; Marta Zientkowska; Melanie Domeyer-Missbach; Sarah Kimmina; Silvia Obenauer; Fritz Kauer; Walter Stühmer; Eckhardt Grabbe; Wolfgang F Vogel; Frauke Alves
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

5.  Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.

Authors:  Tobias Bäuerle; Heidegard Hilbig; Sönke Bartling; Fabian Kiessling; Astrid Kersten; Annette Schmitt-Gräff; Hans-Ulrich Kauczor; Stefan Delorme; Martin R Berger
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

6.  Local loperamide inhibits thermal hyperalgesia but not mechanical allodynia induced by intratibial inoculation of melanoma cells in mice.

Authors:  Verdad Curto-Reyes; Lucía Juárez; Eva García-Pérez; Manuel Florentino Fresno; Agustín Hidalgo; Luis Menéndez; Ana Baamonde
Journal:  Cell Mol Neurobiol       Date:  2008-03-22       Impact factor: 5.046

7.  A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model.

Authors:  Louis Doré-Savard; Nicolas Beaudet; Luc Tremblay; Yongjun Xiao; Martin Lepage; Philippe Sarret
Journal:  Clin Exp Metastasis       Date:  2012-09-06       Impact factor: 5.150

Review 8.  Detecting Tumor Metastases: The Road to Therapy Starts Here.

Authors:  M E Menezes; S K Das; I Minn; L Emdad; X-Y Wang; D Sarkar; M G Pomper; P B Fisher
Journal:  Adv Cancer Res       Date:  2016-08-17       Impact factor: 6.242

9.  The effect of marrow secretome and culture environment on the rate of metastatic breast cancer cell migration in two and three dimensions.

Authors:  Kimberly J Curtis; Christine Mai; Hannah Martin; Alyssa G Oberman; Laura Alderfer; Ricardo Romero-Moreno; Mark Walsh; Stephen F Mitros; Scott G Thomas; Joseph A Dynako; David I Zimmer; Laoise M McNamara; Laurie E Littlepage; Glen L Niebur
Journal:  Mol Biol Cell       Date:  2021-03-10       Impact factor: 4.138

10.  Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma.

Authors:  Melissa A Wilson; Judy Zhong; Paul Johannet; Yesung Lee; Natasha Masub; Todd Wechter; Una Moran; Russell S Berman; Richard L Shapiro; Jeffrey Weber; Anna Pavlick; Iman Osman
Journal:  Melanoma Res       Date:  2020-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.